New Key Statistics Module, Z-Score and F-Score
NAS:SUPN Key Ratios
| Market Cap $ M | 1,490.90 |
| Enterprise Value $ M | 1,235.29 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.60 |
| Price/Sales | 2.50 |
| Price/Free Cash Flow | 15.02 |
| Price/Owner Earnings | 41.53 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 597.00 |
| EPS (TTM) $ | -0.29 |
| Beneish M-Score | -2.61 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -12.10 |
| y-y EBITDA Growth Rate % | -39.80 |
| EV-to-EBIT | -242.45 |
| EV-to-EBITDA | 15.46 |
| PEG | -- |
| Shares Outstanding M | 54.97 |
| Net Margin (%) | -2.60 |
| Operating Margin % | 0.94 |
| Pre-tax Margin (%) | -1.01 |
| Quick Ratio | 1.49 |
| Current Ratio | 1.73 |
| ROA % (ttm) | -1.12 |
| ROE % (ttm) | -1.69 |
| ROIC % (ttm) | 1.46 |
| Dividend Yield % | -- |
| Altman Z-Score | 3.56 |
SUPN Number of Guru Trades
SUPN Volume of Guru Trades
Gurus Latest Trades with NAS:SUPN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SUPN is held by these investors
Total 4
Supernus Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:SUPN
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers